Nevoid basal-cell carcinoma syndrome

From WikiMD's Medical Encyclopedia

(Redirected from Goltz-Gorlin syndrome)

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Nevoid basal-cell carcinoma syndrome
Synonyms Gorlin syndrome, basal cell nevus syndrome
Pronounce
Specialty Dermatology, Genetics
Symptoms Multiple basal cell carcinomas, jaw cysts, skeletal abnormalities, palmar pits
Complications Increased risk of skin cancer, medulloblastoma
Onset Childhood to early adulthood
Duration Lifelong
Types
Causes Mutations in the PTCH1 gene
Risks Family history, genetic predisposition
Diagnosis Clinical evaluation, genetic testing
Differential diagnosis Basal cell carcinoma, xeroderma pigmentosum, Rombo syndrome
Prevention Sun protection, regular skin examinations
Treatment Surgical removal of tumors, vismodegib, radiation therapy
Medication Vismodegib, sonidegib
Prognosis Variable, depends on severity and management
Frequency 1 in 31,000 people
Deaths Rare, related to complications


Nevoid basal-cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare genetic disorder that primarily affects the skin, nervous system, and eyes. It is characterized by the development of multiple basal cell carcinomas (BCCs), odontogenic keratocysts in the jaw, palmar or plantar pits, and various other symptoms.

Signs and Symptoms[edit]

NBCCS is associated with a variety of signs and symptoms, the most common of which are multiple BCCs. These usually appear in adolescence or early adulthood and can be triggered by minimal sun exposure. Other common features include odontogenic keratocysts, which are benign cysts that can cause significant jaw swelling and tooth displacement. Palmar or plantar pits are also common, appearing as small, punctate depressions in the skin of the palms of the hands or soles of the feet.

Causes[edit]

NBCCS is caused by mutations in the PTCH1 gene, which is involved in controlling cell growth and division. This mutation leads to uncontrolled cell growth, particularly in the skin, leading to the development of BCCs.

Diagnosis[edit]

Diagnosis of NBCCS is based on clinical criteria, including the presence of multiple BCCs or a single BCC at a young age, odontogenic keratocysts, palmar or plantar pits, and a family history of the syndrome. Genetic testing can confirm the diagnosis.

Treatment[edit]

Treatment for NBCCS is primarily focused on managing the symptoms. This can include surgery to remove BCCs or odontogenic keratocysts, and regular monitoring for new symptoms.

See Also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.